CYRX Cryoport Inc

Price (delayed)

$8.83

Market cap

$434.94M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.48

Enterprise value

$798.55M

Cryoport, Inc. is redefining temperature-controlled supply chain support for the life sciences industry by continually broadening its platform of solutions, serving the Biopharma, Reproductive Medicine, and Animal Health markets. Through ...

Highlights
The debt has decreased by 6% YoY
The quick ratio has declined by 27% year-on-year and by 9% since the previous quarter
Cryoport's equity has decreased by 16% YoY and by 3.4% from the previous quarter

Key stats

What are the main financial stats of CYRX
Market
Shares outstanding
49.26M
Market cap
$434.94M
Enterprise value
$798.55M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.92
Price to sales (P/S)
1.92
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.55
Earnings
Revenue
$225.03M
EBIT
-$107.61M
EBITDA
-$73.7M
Free cash flow
-$45.24M
Per share
EPS
-$2.48
Free cash flow per share
-$0.92
Book value per share
$9.64
Revenue per share
$4.59
TBVPS
$13.16
Balance sheet
Total assets
$942.85M
Total liabilities
$470.66M
Debt
$414.94M
Equity
$472.19M
Working capital
$476.72M
Liquidity
Debt to equity
0.88
Current ratio
10.73
Quick ratio
10.03
Net debt/EBITDA
-4.93
Margins
EBITDA margin
-32.8%
Gross margin
41.8%
Net margin
-50.2%
Operating margin
-56.2%
Efficiency
Return on assets
-12.3%
Return on equity
-23.7%
Return on invested capital
-11%
Return on capital employed
-12%
Return on sales
-47.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CYRX stock price

How has the Cryoport stock price performed over time
Intraday
-1.45%
1 week
1.85%
1 month
24.37%
1 year
-45.96%
YTD
-43%
QTD
27.79%

Financial performance

How have Cryoport's revenue and profit performed over time
Revenue
$225.03M
Gross profit
$94.04M
Operating income
-$126.39M
Net income
-$112.91M
Gross margin
41.8%
Net margin
-50.2%
The net margin has decreased by 18% from the previous quarter
Cryoport's operating margin has decreased by 14% QoQ
CYRX's gross profit is down by 13% year-on-year and by 5% since the previous quarter
The company's net income fell by 13% QoQ

Growth

What is Cryoport's growth rate over time

Valuation

What is Cryoport stock price valuation
P/E
N/A
P/B
0.92
P/S
1.92
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.55
Cryoport's EPS has decreased by 12% from the previous quarter
CYRX's price to book (P/B) is 77% less than its 5-year quarterly average of 4.1 and 38% less than its last 4 quarters average of 1.5
Cryoport's equity has decreased by 16% YoY and by 3.4% from the previous quarter
CYRX's P/S is 85% below its 5-year quarterly average of 13.4 and 43% below its last 4 quarters average of 3.4
The revenue has declined by 9% year-on-year and by 3.5% since the previous quarter

Efficiency

How efficient is Cryoport business performance
Cryoport's ROS has decreased by 19% from the previous quarter
The company's return on invested capital fell by 18% QoQ
CYRX's return on equity is down by 17% since the previous quarter
The return on assets has declined by 15% since the previous quarter

Dividends

What is CYRX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CYRX.

Financial health

How did Cryoport financials performed over time
The total assets is 100% more than the total liabilities
The quick ratio has declined by 27% year-on-year and by 9% since the previous quarter
The current ratio has contracted by 26% YoY and by 9% from the previous quarter
The debt is 12% less than the equity
Cryoport's equity has decreased by 16% YoY and by 3.4% from the previous quarter
The debt to equity is up by 11% year-on-year and by 3.5% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.